한글목차

맞춤형 유전자 합성 서비스 세계 시장 규모는 2024년 15억 4,000만 달러로 평가되며, 예측 기간 동안 8.54%의 CAGR로 성장하여 2030년에는 25억 2,000만 달러에 달할 것으로 예상됩니다.

이 시장은 생명과학 및 생명공학 산업에서 역동적이고 빠르게 발전하는 분야로 부상하고 있습니다. 맞춤형 유전자 합성 서비스는 DNA 염기서열을 인위적으로 생성하여 연구자와 생명공학 기업이 다양한 용도의 맞춤형 유전물질을 설계하고 얻을 수 있도록 도와줍니다.

유전자 치료, 합성생물학, 백신 개발, 유전공학 등의 분야에서 합성 DNA 구조물에 대한 수요가 증가함에 따라 최근 그 성장세가 두드러지고 있습니다. 맞춤형 의료와 표적 치료의 부상은 주요 촉진요인 중 하나입니다. 분자 수준에서 유전성 질환 및 질병을 치료하기 위한 유전자 치료제 개발에는 맞춤형으로 설계된 DNA 서열이 필수적입니다. 또한, 합성생물학의 확장은 생물학적 시스템을 설계하고 엔지니어링할 수 있는 새로운 기회를 창출하여 합성 DNA에 대한 수요를 더욱 증가시키고 있습니다.

특히 고체상 합성과 같은 유전자 합성 방법의 기술 발전은 DNA 합성의 정확성과 효율성을 향상시켜 시장 성장에 박차를 가하고 있습니다. 유전자 합성 비용의 감소와 서비스 제공자의 증가로 인해 맞춤형 유전자 합성은 모든 규모의 연구자 및 조직에 더욱 친숙해지고 있습니다.

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(1,000 bp 이하, 1001-3,000 bp, 3001-5,000 bp, 5,000 bp 이상)
  • 용도별(상업, 학술 연구)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 캐나다
  • 멕시코

제7장 유럽의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 맞춤형 유전자 합성 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(해당되는 경우)
• 제품 발매(해당되는 경우)

제13장 Porter's Five Forces 분석

• 산업내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• GenScript BIoTech Corporation
• Biomatik Corporation
• Thermo Fisher Scientific Inc.
• Integrated DNA Technologies, Inc.
• Synbio Technologies LLC
• Biomol GmbH
• Eurofins Genomics Germany GmbH
• BioCat GmbH
• Azenta US Inc.
• ProMab BIoTechnologies, Inc.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

영문목차

The global Custom Gene Synthesis Service Market was valued at USD 1.54 billion in 2024 and is projected to reach USD 2.52 billion by 2030, growing at a CAGR of 8.54% during the forecast period. This market has emerged as a dynamic and rapidly evolving sector within the life sciences and biotechnology industries. Custom gene synthesis services involve the artificial creation of DNA sequences, enabling researchers and biotech companies to design and obtain custom genetic material for various applications.

The market has experienced significant growth in recent years, driven by the increasing demand for synthetic DNA constructs across fields such as gene therapy, synthetic biology, vaccine development, and genetic engineering. The rise of personalized medicine and targeted therapies is one of the key drivers. Custom-designed DNA sequences are essential for developing gene therapies aimed at treating genetic disorders and diseases at the molecular level. Additionally, the expansion of synthetic biology has created new opportunities for designing and engineering biological systems, further increasing the demand for synthetic DNA.

Technological advancements, particularly in gene synthesis methods like solid-phase synthesis, have improved the accuracy and efficiency of DNA synthesis, fueling market growth. The reduction in gene synthesis costs, coupled with a growing number of service providers, has made custom gene synthesis more accessible to researchers and organizations of all sizes.

Key Market Drivers

Increasing Demand for Personalized Medicine: Personalized medicine is a significant driver for the growth of the custom gene synthesis service market. This healthcare approach aims to tailor treatments based on an individual's genetic makeup and relies heavily on the precise design and creation of custom DNA sequences. For example, in February 2022, Integrated DNA Technologies, Inc. launched Alt-R HDR Donor Blocks, which facilitate gene editing using Homology-directed Repair (HDR) - a critical tool for developing new treatments.

Custom gene synthesis services are central to the development of personalized treatments by providing the necessary genetic material for advanced therapies. In gene therapy, custom DNA sequences are used to correct or replace faulty genes that cause genetic disorders, ensuring treatments are specific and effective while minimizing side effects. The rise of CRISPR-Cas9 technology, which depends on precisely engineered DNA sequences to target and modify genes, further boosts the demand for custom gene synthesis.

Custom gene synthesis services are also essential in developing treatments for cancer, autoimmune diseases, and rare conditions, as these therapies require the creation of DNA constructs to target the unique genetic markers of individual patients. As personalized medicine continues to gain traction, the demand for custom gene synthesis services is expected to increase significantly.

Key Market Challenges

Cost Constraints: Despite the impressive growth of the custom gene synthesis service market, cost remains a significant challenge to its widespread adoption. One of the primary cost-related challenges is the high expense associated with synthesizing long and complex DNA sequences. Although technological advancements have improved efficiency, DNA production is still relatively costly, posing a barrier for researchers, especially those working with limited budgets in academic institutions or startups. This can limit access to custom gene synthesis services, hindering the broader adoption of this technology.

Another challenge is the variability in pricing among service providers. The absence of standardized pricing models makes it difficult for customers to compare options and select the most cost-effective solutions. This lack of consistency can create confusion and uncertainty among potential users, slowing market growth. Furthermore, the cost of custom gene synthesis services impacts research budgets, limiting researchers' ability to fully utilize these services, potentially delaying research and slowing scientific progress.

Key Market Trends

Emerging Applications in Drug Discovery: Emerging applications in drug discovery are playing a critical role in driving the demand for custom gene synthesis services. The pharmaceutical industry, a significant consumer of these services, is increasingly relying on synthesized DNA constructs for gene function studies, drug target validation, and therapeutic protein production. As drug discovery becomes more complex, the need for precision and customization has risen sharply.

The CRISPR-Cas9 genome editing technology is one of the key innovations fueling the demand for custom gene synthesis. This technology enables precise gene editing, which is essential for identifying and validating potential drug targets. Custom-designed DNA constructs are vital for guiding CRISPR-Cas9 to the specific genomic locations, enabling accurate gene editing.

Additionally, the growing focus on personalized medicine within drug development is driving the demand for custom gene synthesis. Custom DNA sequences are used to create patient-specific models for drug response testing, ensuring that treatments are tailored to individual genetic profiles, which improves drug efficacy and reduces adverse effects.

In June 2023, Eurofins Genomics Blue Heron introduced its In-Vitro Transcription (IVT) Messenger RNA (mRNA) Synthesis Service. This service offers a high-quality, customizable solution for researchers involved in various fields, including molecular biology, drug discovery, vaccine development, and gene therapy.

Key Market Players

• GenScript Biotech Corporation
• Biomatik Corporation
• Thermo Fisher Scientific Inc.
• Integrated DNA Technologies, Inc.
• Synbio Technologies LLC
• Biomol GmbH
• Eurofins Genomics Germany GmbH
• BioCat GmbH
• Azenta US Inc.
• ProMab Biotechnologies, Inc.

Report Scope:

This report segments the Global Custom Gene Synthesis Service Market as follows, along with detailed insights on industry trends:

By Type:

• Below 1000 bp
• 1001 to 3000 bp
• 3001 to 5000 bp
• Above 5000 bp

By Application:

• Commercial
• Academic Research

By Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape: This section provides a detailed analysis of major companies operating in the Global Custom Gene Synthesis Service Market.

Available Customizations: TechSci Research offers customizations to this report to meet the specific needs of a company. Customization options include:

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Custom Gene Synthesis Service Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Below 1000 bp, 1001 to 3000 bp, 3001 to 5000 bp, above 5000 bp)
  • 5.2.2. By Application (Commercial, Academic Research)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Custom Gene Synthesis Service Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Custom Gene Synthesis Service Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Custom Gene Synthesis Service Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Custom Gene Synthesis Service Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Custom Gene Synthesis Service Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Custom Gene Synthesis Service Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Custom Gene Synthesis Service Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Custom Gene Synthesis Service Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. France Custom Gene Synthesis Service Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Custom Gene Synthesis Service Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Custom Gene Synthesis Service Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Custom Gene Synthesis Service Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Custom Gene Synthesis Service Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Custom Gene Synthesis Service Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Custom Gene Synthesis Service Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Custom Gene Synthesis Service Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Custom Gene Synthesis Service Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Custom Gene Synthesis Service Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Custom Gene Synthesis Service Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Custom Gene Synthesis Service Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Custom Gene Synthesis Service Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Custom Gene Synthesis Service Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Custom Gene Synthesis Service Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Custom Gene Synthesis Service Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. GenScript Biotech Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Biomatik Corporation
• 14.3. Thermo Fisher Scientific Inc.
• 14.4. Integrated DNA Technologies, Inc.
• 14.5. Synbio Technologies LLC
• 14.6. Biomol GmbH
• 14.7. Eurofins Genomics Germany GmbH
• 14.8. BioCat GmbH
• 14.9. Azenta US Inc.
• 14.10. ProMab Biotechnologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer